HealthQuad

HealthQuad invests exclusively in Indian healthcare, writing $5M to $25M checks across Series A through Series C. The firm operates from New Delhi and treats healthcare not as a thematic slice of a generalist portfolio but as the entire mandate. Founders pitching HealthQuad are talking to investors who spend their days inside Indian hospital systems, diagnostics chains, and digital care platforms, and that specificity tends to compress the time it takes to get to a real conversation about whether a business actually works.

The thesis spans digital health, medical devices and medtech, and biotech, with growing attention to AI-enabled clinical and operational workflows. HealthQuad looks for companies addressing structural gaps in Indian care delivery: distribution into tier-two and tier-three cities, affordability without sacrificing clinical quality, and infrastructure that lets providers scale without proportional cost. The firm tends to back operators who have spent years inside the sector rather than founders making a first leap into healthcare from adjacent industries, and the portfolio reflects that bias toward domain knowledge over pattern-matching.

Check sizes between $5M and $25M place HealthQuad squarely in growth-stage territory. The firm does not chase pre-seed or seed deals and is honest about that. Companies should expect substantive revenue, clinical validation, and a clear regulatory path before serious diligence begins. Geographically, India is the focus, though portfolio companies frequently expand into adjacent South Asian and Southeast Asian markets, and HealthQuad helps with those moves. The fund’s relationships with Indian hospital networks, payors, and government health programs shape both the deals it sees and the ones it ultimately wins.

The team blends healthcare operating experience with traditional venture investing, drawing on connections across Indian pharma, hospital chains, and the diagnostics industry. That bench gives portfolio companies access to clinical advisors, regulatory specialists, and channel partners who understand how Indian healthcare actually buys and pays for things, which is often the difference between a pilot and a contract.

HealthQuad’s approach to working with founders is hands-on without being intrusive. Partners take board seats and engage on commercial strategy, regulatory navigation, and follow-on financing, but they do not run the company. The firm has a track record of helping portfolio companies bring in strategic co-investors, including domestic strategics and international growth funds, and it leverages its network to open doors with hospital systems and government buyers. Founders who want a healthcare-native partner with check sizes that meaningfully change the trajectory of a Series A or B round, and who are building specifically for India, will find HealthQuad an unusually direct fit. Those building generalist software or pursuing markets outside South Asia should look elsewhere.